A PYMNTS Company

US: Pharma pay-for-delay class action settles

By  |  September 3, 2013

Bayer Corporation, sued along with other pharmaceutical companies in a class action for allegations of pay-for-delay contracts and non-compete agreements, has partially settled with plaintiffs for $74 million, though the additional defendants have yet to reach a similar agreement.

Bayer, along with Barr, Hoechst Marion Roussel, Watson Pharmaceuticals and The Rugby Group, were brought to court for so-called pay-for-delay agreements, alleged to have paid the generic makers of an antibiotic called Cipro to delay sales; the drug companies are refuting the claims.

Members of the class involve buyers of Cipro within California between January 8, 1977 and October 31, 2004.

Full Content: PR Newswire

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.